AVANIR Pharmaceuticals - Class A

FRA:AV2B (USA)   Class A
€ 14.37 (-0.19%) Jan 13
At Loss
P/B:
12.03
Market Cap:
€ 2.69B ($ 2.90B)
Enterprise V:
€ 2.69B ($ 2.90B)
Volume:
-
Avg Vol (2M):
-
Buying
0 ( 0 % )
To
Top 10 Stocks in Buying
Stock Votes
Not interested
0 ( 0 % )
To
Top 10 Stocks in Not interested
Stock Votes
Comments